Vision: To develop novel therapeutics for treatment of diseases of the ear, nose and throat.
History: Founded in 2014
Benjamin F. McGraw, III, PharmD (Executive Chairman)
Sanjay Chanda, PhD (Development Consultant)
Peter Santa Maria, MBBS, PhD, FRACS (Chairman, SAB)
AU-935 (HB-EGF), non-surgical repair of tympanic membranes
AU-934 (KB-R7785) alternative to tympanotomy tubes
Undisclosed research stage products